KMTS

KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS

NasdaqSmall CapHealthcare
InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro quality score

Rank #2,533 of 2,925

Why it scores 28Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$30.97M

Quarter to Jul 31

Net income

$-44.09M

Quarter to Jul 31

Free cash flow

$-40.63M

Quarter to Jul 31

Operating margin

-121.6%

Quarter to Jul 31

Top Institutional Holders

as of Q2 2026
$1.49B total
BAIN CAPITAL INVESTORS LLC
$640.38M0.0%
FMR LLC
$140.52M-3.5%
PRICE T ROWE ASSOCIATES INC /MD/
$126.41M-16.8%
Andera Partners
$69.42M+1.2%
Yu Fan
$58.07M0.0%
BROWN ADVISORY INC
$48.57M+10.8%
BlackRock, Inc.
$47.46M+10.4%
EVENTIDE ASSET MANAGEMENT, LLC
$36.80M+0.1%
VANGUARD CAPITAL MANAGEMENT LLC
$29.91M-3.1%
ALLIANCEBERNSTEIN L.P.
$29.46M+11.9%
FRANKLIN RESOURCES INC
$28.58M-9.6%
Omega Fund Management, LLC
$26.00M0.0%
Hood River Capital Management LLC
$19.17M+14.9%
STATE STREET CORP
$19.02M+11.4%
GEODE CAPITAL MANAGEMENT, LLC
$16.47M+12.8%
Point72 Asset Management, L.P.
$13.40MNew
FEDERATED HERMES, INC.
$13.36M0.0%
NEXT CENTURY GROWTH INVESTORS LLC
$11.66M+0.2%
DRIEHAUS CAPITAL MANAGEMENT LLC
$11.41M+0.3%
UBS Group AG
$8.29M-6.8%
GOLDMAN SACHS GROUP INC
$7.74M+5.6%
Schonfeld Strategic Advisors LLC
$7.28M+151.4%
VANGUARD PORTFOLIO MANAGEMENT LLC
$6.50M+16.7%
SEI INVESTMENTS CO
$6.11M+1.2%
NORTHERN TRUST CORP
$5.30M+8.7%
See all 109 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q1 2027
EDGAR

Net Income

Q1 2027
EDGAR

EPS (Diluted)

Q1 2027
EDGAR

Operating Margin

Q1 2027
EDGAR

ROIC

Q1 2027
EDGAR

Free Cash Flow

Q1 2027
EDGAR

Debt/Equity

Q1 2027
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/KMTS

Earnings Per Share

13fpro.ai/company/KMTS

Loading ratio trend…

About KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS): stock profile, AI score and financials

KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores KMTS at 28.1/100 on a composite quality score built from its SEC filings, placing it at rank #2,533 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q1 2027), KESTRA MEDICAL TECHNOLOGIES, LTD. reports quarterly revenue of $31.0M, net income of $-44.1M, an operating margin of -121.6%. KMTS trades on the Nasdaq exchange and files with the SEC under CIK 1877184. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate KMTS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for KESTRA MEDICAL TECHNOLOGIES, LTD. directly from SEC EDGAR.

SEC EDGAR: CIK 1877184 →